Full-Service CRO
Gene
Virus
RNA
Cell
Microbiology
Animal
Biologics CDMO
Plasmid
AAV
RNA
Antibody
Protein
Biosimilar
Proteins
Recombinant Drug Target Proteins
Delivering research to GMP-grade proteins with exceptional batch-to-batch consistency and pharmacopeia-compliant manufacturing. Our multi-tiered product portfolio ensures >95% purity, controlled endotoxin levels (<1.0 EU/µg), and comprehensive CoA documentation meeting global regulatory requirements.
QVirusTM
Creative Biogene provides high-titer viral vector packaging solutions, ensuring efficient gene delivery across diverse cell types, from custom designs to large-scale production, streamlining your path from research to industrial production.
RNA
With expertise in GMP-grade synthesis, innovative delivery systems (liposomes, LNPs, exosomes), and comprehensive CMC support, Creative Biogene optimizes every step of your RNA drug development pathway.
CHO
An extremely productive and stable expression system for drug development and manufacturing.
CDMO
Creative Biogene pioneers breakthrough solutions in biopharmaceutical development. Our deep expertise empowers partners to transform innovative therapies from concept to commercialization, accelerating next-generation biologics, gene therapies, and vaccines to market.
Gene Editing
Accelerate your discoveries with our comprehensive portfolio of cell lines and animal models. Choose from ready-made knockout/knockin options or let our expert team create custom genetic modifications tailored to your needs.
Microbiology
Master microbial fermentation from bench to commercial scale with our integrated platform. Creative Biogene’s cGMP-certified facilities combine advanced strain engineering with robust production capabilities, delivering optimized yields for your research and industrial applications.
Services
Products
Platforms
In the area of stable cell line generation, decades of experience with cell culture optimization and exclusive expression vectors allow for the quick and dependable creation of customized cell lines for applications such as gene knockdown, protein expression, and genome editing.
Extensive vector engineering knowledge supports high-titer viral production across AAV, Adenovirus, Lentivirus, and Retrovirus systems for gene therapy and vaccine research, building on sophisticated viral packaging platforms.
Advanced platforms at the vanguard of microRNA research use functional screening, thorough profiling, and targeted production of agomirs, antagomirs, and miRNA sponges to speed up gene regulatory findings.
Leading-edge nucleotide services utilize cutting-edge synthesis methods to produce plasmids, facilitate cloning, and provide precision gene synthesis, allowing for advances in molecular biology and medicine.
Through the optimized design of siRNA, shRNA, and miRNA vectors, advanced RNA interference knowledge propels advancements in gene silencing, facilitating drug discovery and functional genomics with high-throughput screening capabilities.
Cutting-edge genome editing in microorganisms uses recombination and CRISPR/Cas9 technology to improve industrial strains, increasing productivity for use in agriculture and medicine.
A thorough understanding of library design speeds up screening and discovery research by enabling the production of higher recombination-rate cDNA, genomic, BAC, and mutant libraries.
Innovative target-based drug discovery combines biochemical and cell-based screening expertise across multiple target classes, accelerating therapeutic development through rigorous compound profiling and evaluation.
In the area of stable cell line generation, decades of experience with cell culture optimization and exclusive expression vectors allow for the quick and dependable creation of customized cell lines for applications such as gene knockdown, protein expression, and genome editing.
Extensive vector engineering knowledge supports high-titer viral production across AAV, Adenovirus, Lentivirus, and Retrovirus systems for gene therapy and vaccine research, building on sophisticated viral packaging platforms.
Advanced platforms at the vanguard of microRNA research use functional screening, thorough profiling, and targeted production of agomirs, antagomirs, and miRNA sponges to speed up gene regulatory findings.
Leading-edge nucleotide services utilize cutting-edge synthesis methods to produce plasmids, facilitate cloning, and provide precision gene synthesis, allowing for advances in molecular biology and medicine.
Through the optimized design of siRNA, shRNA, and miRNA vectors, advanced RNA interference knowledge propels advancements in gene silencing, facilitating drug discovery and functional genomics with high-throughput screening capabilities.
Cutting-edge genome editing in microorganisms uses recombination and CRISPR/Cas9 technology to improve industrial strains, increasing productivity for use in agriculture and medicine.
A thorough understanding of library design speeds up screening and discovery research by enabling the production of higher recombination-rate cDNA, genomic, BAC, and mutant libraries.
Innovative target-based drug discovery combines biochemical and cell-based screening expertise across multiple target classes, accelerating therapeutic development through rigorous compound profiling and evaluation.
In the area of stable cell line generation, decades of experience with cell culture optimization and exclusive expression vectors allow for the quick and dependable creation of customized cell lines for applications such as gene knockdown, protein expression, and genome editing.
Extensive vector engineering knowledge supports high-titer viral production across AAV, Adenovirus, Lentivirus, and Retrovirus systems for gene therapy and vaccine research, building on sophisticated viral packaging platforms.
Advanced platforms at the vanguard of microRNA research use functional screening, thorough profiling, and targeted production of agomirs, antagomirs, and miRNA sponges to speed up gene regulatory findings.
Leading-edge nucleotide services utilize cutting-edge synthesis methods to produce plasmids, facilitate cloning, and provide precision gene synthesis, allowing for advances in molecular biology and medicine.
Through the optimized design of siRNA, shRNA, and miRNA vectors, advanced RNA interference knowledge propels advancements in gene silencing, facilitating drug discovery and functional genomics with high-throughput screening capabilities.
Cutting-edge genome editing in microorganisms uses recombination and CRISPR/Cas9 technology to improve industrial strains, increasing productivity for use in agriculture and medicine.
A thorough understanding of library design speeds up screening and discovery research by enabling the production of higher recombination-rate cDNA, genomic, BAC, and mutant libraries.
Innovative target-based drug discovery combines biochemical and cell-based screening expertise across multiple target classes, accelerating therapeutic development through rigorous compound profiling and evaluation.
Cell Line Service
Viral Service
MicroRNA Service
Nucleotides Service
RNAi Service
Microbe Service
Library Construction
Drug Discovery
MicroRNAs comprise a novel class of endogenous, small (only about 20 to 25 nucleotides), and noncoding RNAs, and almost involved in the physiologic and pathologic process...
Creative Biogene has built-up leading scientific, technical and commercial track records, successfully advancing therapeutic programs for numerous major industry and academic...
Our portfolio includes 500+ validated drug targets across membrane receptors, immune checkpoints, enzymes, and nuclear regulators. Each protein ensures consistent quality through...
Stable cell lines with specific gene over-expression or knock-down are very helpful in gene function analysis, target discovery, target validation, assay development, and compound...
Creative Biogene provides world-class packaging services for a variety of viral types using our QVirusTM platform. Creative Biogene's state-of-the-art facilities and highly...
MicroRNAs comprise a novel class of endogenous, small (only about 20 to 25 nucleotides), and noncoding RNAs, and almost involved in the physiologic and pathologic process...
Creative Biogene has built-up leading scientific, technical and commercial track records, successfully advancing therapeutic programs for numerous major industry and academic...
Our portfolio includes 500+ validated drug targets across membrane receptors, immune checkpoints, enzymes, and nuclear regulators. Each protein ensures consistent quality through...
Stable cell lines with specific gene over-expression or knock-down are very helpful in gene function analysis, target discovery, target validation, assay development, and compound...
Creative Biogene provides world-class packaging services for a variety of viral types using our QVirusTM platform. Creative Biogene's state-of-the-art facilities and highly...
MicroRNAs comprise a novel class of endogenous, small (only about 20 to 25 nucleotides), and noncoding RNAs, and almost involved in the physiologic and pathologic process...
CRISPR/Cas9 PlatformCB owned by Creative Biogene performs gene knockout/knockin program with the CRISPR/Cas9 system, from designing gRNA constructs to transfection and single clone generation of a wide range of cells, including difficult-to-transfect and tumor cell lines, as well as plants, mouse and other animal models.
From many years of groundbreaking work with virus vector design to the latest gene therapy technology support, our QVirusTM Platform offers a comprehensive portfolio of services for the efficient design, development, manufacturing, and analytical testing of virus vector products.
Complete solutions are provided for RNA discovery, expression analysis, functional research, and mechanism analysis. Our next-generation sequencing and microarray platforms enable researchers to explore the world of RNA on an unprecedented scale and map all RNAS involved in cell life programs, human diseases, and drug discovery.
We are fully engaged in developing unique technologies to facilitate the investigation of microbial research. Our high-quality products and services include microbial genome editing, identification, sequencing proteomics, and metabolomics. We possess a mature fermentation platform consisting of large fermentation tanks, bioreactors, and large-scale purification systems.
The one-stop zebrafish R&D service platform delivers reliable, cost-effective solutions across drug development, toxicity testing, and basic research, harnessing the unique advantages of zebrafish models to accelerate discovery and ensure high-quality results.
CRISPR/Cas9 PlatformCB
QvirusTM Platform
IntegrateRNA Platform
Microbiology Platform
Zebrafish Platform
Tel
1-631-626-9181 (USA)
44-208-123-7131 (Europe)
Fax
1-631-614-7828
USA
SUITE 115, 17 Ramsey Road, Shirley, NY 11967, USA
Germany
Industriepark Höchst, Gebäude G830 65929 Frankfurt am Main
Copyright © 2025 Creative Biogene. All rights reserved.